{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:49:53Z","timestamp":1772855393488,"version":"3.50.1"},"reference-count":72,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2023,9,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Many degenerative disorders have started to develop as a result of the deposition of insoluble\nprotein fibrillar clumps known as amyloid. This deposition mostly limits normal cellular\nfunction and signaling. This build-up of amyloid in vivo results in a variety of illnesses in the body,\nincluding type 2 diabetes, several neurodegenerative diseases (such as Alzheimer's disease and\nspongiform encephalopathy), and Alzheimer's disease. Growing interest has been demonstrated in\nnanoparticles as a potential treatments for amyloidosis throughout the past few decades. Inorganic\nnanoparticles are one of them and have also been in substantial research as a potential anti-amyloid\ndrug. Inorganic nanoparticles have emerged as a good study candidates because of their nano size,\ndistinctive physical characteristics, and capacity to traverse the blood-brain barrier. In the current\nreview, we have focused on the effects of different types of inorganic nanoparticles on amyloidogenesis\nand attempted to understand their underlying mechanism of action.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866530666230705153229","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T09:43:49Z","timestamp":1688636629000},"page":"640-652","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Comprehensive Review on Inorganic Nanoparticles as Effective\nModulators of Amyloidogenesis"],"prefix":"10.2174","volume":"30","author":[{"given":"Debashmita","family":"Chakraborty","sequence":"first","affiliation":[{"name":"Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela, 769008, Odisha, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela,\n769008, Odisha, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-0629","authenticated-orcid":true,"given":"Nandini","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela,\n769008, Odisha, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/13506129.2010.526812","volume":"17","author":"Sipe J.D.","year":"2010","unstructured":"Sipe J.D.; Benson M.D.; Buxbaum J.N.; Ikeda S.I.; Merlini G.; Saraiva M.J.M.; Westermark P.; Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010,17(3-4),101-104","journal-title":"Amyloid"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1016\/S1359-0278(98)00002-9","volume":"3","author":"Fink A.L.","year":"1998","unstructured":"Fink A.L.; Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 1998,3(1),R9-R23","journal-title":"Fold Des"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tibs.2007.03.003","volume":"32","author":"Fowler D.M.","year":"2007","unstructured":"Fowler D.M.; Koulov A.V.; Balch W.E.; Kelly J.W.; Functional amyloid \u2013 from bacteria to humans. Trends Biochem Sci 2007,32(5),217-224","journal-title":"Trends Biochem Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"Eisenberg D.","year":"2012","unstructured":"Eisenberg D.; Jucker M.; The amyloid state of proteins in human diseases. Cell 2012,148(6),1188-1203","journal-title":"Cell"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/82815","volume":"7","author":"Kelly J.W.","year":"2000","unstructured":"Kelly J.W.; Mechanisms of amyloidogenesis. Nat Struct Biol 2000,7(10),824-826","journal-title":"Nat Struct Biol"},{"key":"ref=6","first-page":"18","volume":"3","author":"Parijat P.","year":"2016","unstructured":"Parijat P.; Mandeep D.; A brief review on inorganic nanoparticles. J Crit Rev 2016,3(3),18-26","journal-title":"J Crit Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1477-3155-10-31","volume":"10","author":"Fakruddin M.","year":"2012","unstructured":"Fakruddin M.; Hossain Z.; Afroz H.; Prospects and applications of nanobiotechnology: A medical perspective. J Nanobiotechnology 2012,10(1),31","journal-title":"J Nanobiotechnology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"Daneman R.","year":"2015","unstructured":"Daneman R.; Prat A.; The blood-brain barrier. Cold Spring Harb Perspect Biol 2015,7(1),a020412","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics10040269","volume":"10","author":"Teleanu D.","year":"2018","unstructured":"Teleanu D.; Chircov C.; Grumezescu A.; Volceanov A.; Teleanu R.; Blood-brain delivery methods using nanotechnology. Pharmaceutics 2018,10(4),269","journal-title":"Pharmaceutics"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","volume":"13","author":"Ce\u00f1a V.","year":"2018","unstructured":"Ce\u00f1a V.; J\u00e1tiva P.; Nanoparticle crossing of blood\u2013brain barrier: A road to new therapeutic approaches to central nervous system diseases. Nanomedicine (Lond) 2018,13(13),1513-1516","journal-title":"Nanomedicine (Lond)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","volume":"270","author":"Zhou Y.","year":"2018","unstructured":"Zhou Y.; Peng Z.; Seven E.S.; Leblanc R.M.; Crossing the blood-brain barrier with nanoparticles. J Control Release 2018,270,290-303","journal-title":"J Control Release"},{"key":"ref=12","first-page":"149","author":"Gallardo-Toledo E.","year":"2020","unstructured":"Gallardo-Toledo E.; Velasco-Aguirre C.; Kogan M.J.; Inorganic nanoparticles and their strategies to enhance Brain Drug Delivery. Neuromethods 2020,149-172","journal-title":"Neuromethods"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1748-0132(08)70014-8","volume":"3","author":"Lynch I.","year":"2008","unstructured":"Lynch I.; Dawson K.A.; Protein-nanoparticle interactions. Nano Today 2008,3(1-2),40-47","journal-title":"Nano Today"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"8336","DOI":"10.1021\/la904758j","volume":"26","author":"Turci F.","year":"2010","unstructured":"Turci F.; Ghibaudi E.; Colonna M.; Boscolo B.; Fenoglio I.; Fubini B.; An integrated approach to the study of the interaction between proteins and nanoparticles. Langmuir 2010,26(11),8336-8346","journal-title":"Langmuir"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12868-017-0369-9","volume":"18","author":"Yarjanli Z.","year":"2017","unstructured":"Yarjanli Z.; Ghaedi K.; Esmaeili A.; Rahgozar S.; Zarrabi A.; Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci 2017,18(1),51","journal-title":"BMC Neurosci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"14469","DOI":"10.1039\/D1NR03190B","volume":"13","author":"Capocefalo A.","year":"2021","unstructured":"Capocefalo A.; Deckert-Gaudig T.; Brasili F.; Postorino P.; Deckert V.; Unveiling the interaction of protein fibrils with gold nanoparticles by plasmon enhanced nano-spectroscopy. Nanoscale 2021,13(34),14469-14479","journal-title":"Nanoscale"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/nano8090740","volume":"8","author":"Pansieri J.","year":"2018","unstructured":"Pansieri J.; Gerstenmayer M.; Lux F.; M\u00e9riaux S.; Tillement O.; Forge V.; Larrat B.; Marquette C.; Magnetic nanoparticles applications for amyloidosis study and detection: A Review. Nanomaterials 2018,8(9),740","journal-title":"Nanomaterials"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1002\/chem.201806262","volume":"25","author":"Antosova A.","year":"2019","unstructured":"Antosova A.; Bednarikova Z.; Koneracka M.; Antal I.; Marek J.; Kubovcikova M.; Zavisova V.; Jurikova A.; Gazova Z.; Amino acid functionalized superparamagnetic nanoparticles inhibit lysozyme amyloid fibrillization. Chemistry 2019,25(31),7501-7514","journal-title":"Chemistry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"225106","DOI":"10.1088\/0957-4484\/20\/22\/225106","volume":"20","author":"Skaat H.","year":"2009","unstructured":"Skaat H.; Belfort G.; Margel S.; Synthesis and characterization of fluorinated magnetic core\u2013shell nanoparticles for inhibition of insulin amyloid fibril formation. Nanotechnology 2009,20(22),225106","journal-title":"Nanotechnology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ijbiomac.2020.03.061","volume":"153","author":"Yan C.","year":"2020","unstructured":"Yan C.; Zhang N.; Guan P.; Chen P.; Ding S.; Hou T.; Hu X.; Wang J.; Wang C.; Drug-based magnetic imprinted nanoparticles: Enhanced lysozyme amyloid fibrils cleansing and anti-amyloid fibrils toxicity. Int J Biol Macromol 2020,153,723-735","journal-title":"Int J Biol Macromol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1021\/acschemneuro.9b00292","volume":"10","author":"Giannousi K.","year":"2019","unstructured":"Giannousi K.; Antonoglou O.; Dendrinou-Samara C.; Interplay between amyloid fibrillation delay and degradation by magnetic zinc-doped ferrite nanoparticles. ACS Chem Neurosci 2019,10(8),3796-3804","journal-title":"ACS Chem Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"14805","DOI":"10.1021\/acsomega.9b01392","volume":"4","author":"Singla R.","year":"2019","unstructured":"Singla R.; Abidi S.M.S.; Dar A.I.; Acharya A.; Inhibition of glycation-induced aggregation of human serum albumin by organic\u2013inorganic hybrid nanocomposites of iron oxide-functionalized nanocellulose. ACS Omega 2019,4(12),14805-14819","journal-title":"ACS Omega"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1039\/C6BM00764C","volume":"5","author":"Wang M.","year":"2017","unstructured":"Wang M.; Kakinen A.; Pilkington E.H.; Davis T.P.; Ke P.C.; Differential effects of silver and iron oxide nanoparticles on IAPP amyloid aggregation. Biomater Sci 2017,5(3),485-493","journal-title":"Biomater Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.1021\/acs.chemmater.1c01947","volume":"33","author":"Andrikopoulos N.","year":"2021","unstructured":"Andrikopoulos N.; Song Z.; Wan X.; Douek A.M.; Javed I.; Fu C.; Xing Y.; Xin F.; Li Y.; Kakinen A.; Koppel K.; Qiao R.; Whittaker A.K.; Kaslin J.; Davis T.P.; Song Y.; Ding F.; Ke P.C.; Inhibition of amyloid aggregation and toxicity with janus iron oxide nanoparticles. Chem Mater 2021,33(16),6484-6500","journal-title":"Chem Mater"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"129941","DOI":"10.1016\/j.bbagen.2021.129941","volume":"1865","author":"Antosova A.","year":"2021","unstructured":"Antosova A.; Gancar M.; Bednarikova Z.; Marek J.; Zahn D.; Dutz S.; Gazova Z.; Surface-modified magnetite nanoparticles affect lysozyme amyloid fibrillization. Biochim Biophys Acta, Gen Subj 2021,1865(9),129941","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1021\/acsanm.7b00245","volume":"1","author":"Pradhan N.","year":"2018","unstructured":"Pradhan N.; Jana N.R.; Jana N.R.; Inhibition of protein aggregation by iron oxide nanoparticles conjugated with glutamine- and proline-based osmolytes. ACS Appl Nano Mater 2018,1(3),1094-1103","journal-title":"ACS Appl Nano Mater"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1021\/cn300196n","volume":"4","author":"Mahmoudi M.","year":"2013","unstructured":"Mahmoudi M.; Quinlan-Pluck F.; Monopoli M.P.; Sheibani S.; Vali H.; Dawson K.A.; Lynch I.; Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid \u03b2 protein fibrillation in solution. ACS Chem Neurosci 2013,4(3),475-485","journal-title":"ACS Chem Neurosci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.msec.2015.10.026","volume":"59","author":"Mirsadeghi S.","year":"2016","unstructured":"Mirsadeghi S.; Shanehsazzadeh S.; Atyabi F.; Dinarvand R.; Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process. Mater Sci Eng C 2016,59,390-397","journal-title":"Mater Sci Eng C"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3390\/ijms19061815","volume":"19","author":"Song M.","year":"2018","unstructured":"Song M.; Sun Y.; Luo Y.; Zhu Y.; Liu Y.; Li H.; Exploring the mechanism of inhibition of au nanoparticles on the aggregation of amyloid-\u03b2(16-22) peptides at the atom level by all-atom molecular dynamics. Int J Mol Sci 2018,19(6),1815","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1038\/s41598-020-64010-7","volume":"10","author":"Meesaragandla B.","year":"2020","unstructured":"Meesaragandla B.; Karanth S.; Janke U.; Delcea M.; Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation. Sci Rep 2020,10(1),7862","journal-title":"Sci Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.apsusc.2018.12.157","volume":"473","author":"Kumar Ban D.","year":"2019","unstructured":"Kumar Ban D.; Paul S.; Functionalized gold and silver nanoparticles modulate amyloid fibrillation, defibrillation and cytotoxicity of lysozyme via altering protein surface character. Appl Surf Sci 2019,473,373-385","journal-title":"Appl Surf Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1021\/acs.bioconjchem.8b00797","volume":"30","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; Xin Y.; Li Y.; Yang X.; Luo L.; Meng F.; Ultraeffective inhibition of amyloid fibril assembly by nanobody\u2013gold nanoparticle conjugates. Bioconjug Chem 2019,30(1),29-33","journal-title":"Bioconjug Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/chem.201404562","volume":"21","author":"Gao N.","year":"2015","unstructured":"Gao N.; Sun H.; Dong K.; Ren J.; Qu X.; Gold-nanoparticle-based multifunctional amyloid-\u03b2 inhibitor against Alzheimer\u2019s disease. Chemistry 2015,21(2),829-835","journal-title":"Chemistry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1038\/s41467-019-11762-0","volume":"10","author":"Javed I.","year":"2019","unstructured":"Javed I.; Peng G.; Xing Y.; Yu T.; Zhao M.; Kakinen A.; Faridi A.; Parish C.L.; Ding F.; Davis T.P.; Ke P.C.; Lin S.; Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat Commun 2019,10(1),3780","journal-title":"Nat Commun"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41467-020-18525-2","volume":"11","author":"Hou K.","year":"2020","unstructured":"Hou K.; Zhao J.; Wang H.; Li B.; Li K.; Shi X.; Wan K.; Ai J.; Lv J.; Wang D.; Huang Q.; Wang H.; Cao Q.; Liu S.; Tang Z.; Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer\u2019s disease. Nat Commun 2020,11(1),4790","journal-title":"Nat Commun"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.bbamem.2018.03.029","volume":"1860","author":"Peretz Y.","year":"2018","unstructured":"Peretz Y.; Malishev R.; Kolusheva S.; Jelinek R.; Nanoparticles modulate membrane interactions of human Islet amyloid polypeptide (hIAPP). Biochim Biophys Acta Biomembr 2018,1860(9),1810-1817","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1039\/C7NR00699C","volume":"9","author":"Gao G.","year":"2017","unstructured":"Gao G.; Zhang M.; Gong D.; Chen R.; Hu X.; Sun T.; The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-\u03b2 fibrillation. Nanoscale 2017,9(12),4107-4113","journal-title":"Nanoscale"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"118199","DOI":"10.1016\/j.saa.2020.118199","volume":"233","author":"Sharma V.","year":"2020","unstructured":"Sharma V.; Sharma S.; Rana S.; Ghosh K.S.; Inhibition of amyloid fibrillation of human \u03b3D-crystallin by gold nanoparticles: Studies at molecular level. Spectrochim Acta A Mol Biomol Spectrosc 2020,233,118199","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.ijbiomac.2018.09.006","volume":"120","author":"Alam M.T.","year":"2018","unstructured":"Alam M.T.; Rauf M.A.; Siddiqui G.A.; Owais M.; Naeem A.; Green synthesis of silver nanoparticles, its characterization, and chaperone-like activity in the aggregation inhibition of \u03b1-chymotrypsinogen A. Int J Biol Macromol 2018,120(Pt B),2381-2389","journal-title":"Int J Biol Macromol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/molecules27030944","volume":"27","author":"Rauf M.A.","year":"2022","unstructured":"Rauf M.A.; Alam M.T.; Ishtikhar M.; Ali N.; Alghamdi A.; AlAsmari A.F.; Investigating chaperone like activity of green silver nanoparticles: Possible implications in drug development. Molecules 2022,27(3),944","journal-title":"Molecules"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"117508","DOI":"10.1016\/j.molliq.2021.117508","volume":"342","author":"Vus K.","year":"2021","unstructured":"Vus K.; Tarabara U.; Danylenko I.; Pirko Y.; Krupodorova T.; Yemets A.; Blume Y.; Turchenko V.; Klymchuk D.; Smertenko P.; Zhytniakivska O.; Trusova V.; Petrushenko S.; Bogatyrenko S.; Gorbenko G.; Silver nanoparticles as inhibitors of insulin amyloid formation: A fluorescence study. J Mol Liq 2021,342,117508","journal-title":"J Mol Liq"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1021\/acs.langmuir.9b00080","volume":"35","author":"Sudhakar S.","year":"2019","unstructured":"Sudhakar S.; Mani E.; Rapid dissolution of amyloid \u03b2 fibrils by silver nanoplates. Langmuir 2019,35(21),6962-6970","journal-title":"Langmuir"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1906674","DOI":"10.1002\/smll.201906674","volume":"16","author":"Huma Z.","year":"2020","unstructured":"Huma Z.; Javed I.; Zhang Z.; Bilal H.; Sun Y.; Hussain S.Z.; Davis T.P.; Otzen D.E.; Landersdorfer C.B.; Ding F.; Hussain I.; Ke P.C.; Nanosilver mitigates biofilm formation via FAPC amyloidosis inhibition. Small 2020,16(21),1906674","journal-title":"Small"},{"key":"ref=44","volume":"16","author":"Ramshini H","year":"2018","unstructured":"Ramshini H; Moghaddasi A.S.; Ability of silver nanoparticles to inhibit amyloid aggregation and their potential role in prevention of alzheimer's disease. J School Public Health Inst Public Health Res (2).2018,16","journal-title":"J School Public Health Inst Public Health Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"31587","DOI":"10.1021\/acsami.6b11549","volume":"8","author":"Ban D.K.","year":"2016","unstructured":"Ban D.K.; Paul S.; Nano Zinc oxide inhibits fibrillar growth and suppresses cellular toxicity of lysozyme amyloid. ACS Applied Materials andamp. ACS Appl Mater Interfaces 2016,8(46),31587-31601","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijbiomac.2020.01.269","volume":"150","author":"Asthana S.","year":"2020","unstructured":"Asthana S.; Bhattacharyya D.; Kumari S.; Nayak P.S.; Saleem M.; Bhunia A.; Jha S.; Interaction with zinc oxide nanoparticle kinetically traps \u03b1-synuclein fibrillation into off-pathway non-toxic intermediates. Int J Biol Macromol 2020,150,68-79","journal-title":"Int J Biol Macromol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.msec.2019.03.086","volume":"101","author":"Girigoswami A.","year":"2019","unstructured":"Girigoswami A.; Ramalakshmi M.; Akhtar N.; Metkar S.K.; Girigoswami K.; ZnO Nanoflower petals mediated amyloid degradation - An in vitro electrokinetic potential approach. Mater Sci Eng C 2019,101,169-178","journal-title":"Mater Sci Eng C"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.biopha.2018.12.146","volume":"111","author":"Khurana A.","year":"2019","unstructured":"Khurana A.; Tekula S.; Saifi M.A.; Venkatesh P.; Godugu C.; Therapeutic applications of selenium nanoparticles. Biomed Pharmacother 2019,111,802-812","journal-title":"Biomed Pharmacother"},{"key":"ref=49","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-30930-5","author":"Rai M","year":"2019","unstructured":"Rai M; Yadav A.;  Nanobiotechnology in Neurodegenerative Diseases 2019","journal-title":"Nanobiotechnology in Neurodegenerative Diseases"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.1007\/s00216-022-04285-z","volume":"414","author":"Vicente-Zurdo D.","year":"2022","unstructured":"Vicente-Zurdo D.; Rodr\u00edguez-Bl\u00e1zquez S.; G\u00f3mez-Mej\u00eda E.; Rosales-Conrado N.; Le\u00f3n-Gonz\u00e1lez M.E.; Madrid Y.; Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer\u2019s disease. Anal Bioanal Chem 2022,414(26),7573-7584","journal-title":"Anal Bioanal Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.actbio.2015.06.035","volume":"25","author":"Yin T.","year":"2015","unstructured":"Yin T.; Yang L.; Liu Y.; Zhou X.; Sun J.; Liu J.; Sialic acid (SA)-modified selenium nanoparticles coated with a high blood\u2013brain barrier permeability peptide-B6 peptide for potential use in Alzheimer\u2019s disease. Acta Biomater 2015,25,172-183","journal-title":"Acta Biomater"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.12871\/00039829202123","volume":"159","author":"Ramshini H.","year":"2021","unstructured":"Ramshini H.; Rostami S.; Dual function of Selenium nanoparticles: Inhibition or induction of lysozyme amyloid aggregation and evaluation of their cell based cytotoxicity. Arch Ital Biol 2021,159(2),82-94","journal-title":"Arch Ital Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"21116","DOI":"10.1021\/acsami.7b03816","volume":"9","author":"Han Q.","year":"2017","unstructured":"Han Q.; Cai S.; Yang L.; Wang X.; Qi C.; Yang R.; Wang C.; Molybdenum disulfide nanoparticles as multifunctional inhibitors against alzheimer\u2019s disease. ACS Applied Materials andamp. ACS Appl Mater Interfaces 2017,9(25),21116-21123","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1039\/C8TB02964D","volume":"7","author":"Ma Y.","year":"2019","unstructured":"Ma Y.; Huang R.; Qi W.; Su R.; He Z.; Fluorescent silicon nanoparticles inhibit the amyloid fibrillation of insulin. J Mater Chem B Mater Biol Med 2019,7(9),1397-1403","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1021\/acs.jcim.8b00725","volume":"59","author":"Zhou S.","year":"2019","unstructured":"Zhou S.; Zhu Y.; Yao X.; Liu H.; Carbon nanoparticles inhibit the aggregation of prion protein as revealed by experiments and atomistic simulations. J Chem Inf Model 2019,59(5),1909-1918","journal-title":"J Chem Inf Model"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijbiomac.2022.03.006","volume":"207","author":"Jaragh-Alhadad L.A.","year":"2022","unstructured":"Jaragh-Alhadad L.A.; Falahati M.; Copper oxide nanoparticles promote amyloid-\u03b2-triggered neurotoxicity through formation of oligomeric species as a prelude to Alzheimer\u2019s diseases. Int J Biol Macromol 2022,207,121-129","journal-title":"Int J Biol Macromol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"115051","DOI":"10.1016\/j.molliq.2020.115051","volume":"323","author":"Lyu J.","year":"2021","unstructured":"Lyu J.; Long X.; Xie T.; Jiang G.; Jiang J.; Ye L.; Li Q.; Copper oxide nanoparticles promote \u03b1-synuclein oligomerization and underlying neurotoxicity as a model of Parkinson\u2019s disease. J Mol Liq 2021,323,115051","journal-title":"J Mol Liq"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/biomedicines8030045","volume":"8","author":"Mou X.","year":"2020","unstructured":"Mou X.; Pilozzi A.; Tailor B.; Yi J.; Cahill C.; Rogers J.; Huang X.; Exposure to cuo nanoparticles mediates NFKB activation and enhances amyloid precursor protein expression. Biomedicines 2020,8(3),45","journal-title":"Biomedicines"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00775-014-1132-7","volume":"19","author":"Migliorini C.","year":"2014","unstructured":"Migliorini C.; Sinicropi A.; Kozlowski H.; Luczkowski M.; Valensin D.; Copper-induced structural propensities of the amyloidogenic region of human prion protein. J Biol Inorg Chem 2014,19(4-5),635-645","journal-title":"J Biol Inorg Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","volume":"273","author":"Atwood C.S.","year":"1998","unstructured":"Atwood C.S.; Moir R.D.; Huang X.; Scarpa R.C.; Bacarra N.M.E.; Romano D.M.; Hartshorn M.A.; Tanzi R.E.; Bush A.I.; Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 1998,273(21),12817-12826","journal-title":"J Biol Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"126777","DOI":"10.1016\/j.jtemb.2021.126777","volume":"67","author":"Cendrowska-Pinkosz M.","year":"2021","unstructured":"Cendrowska-Pinkosz M.; Krauze M.; Ju\u015bkiewicz J.; Ognik K.; The effect of the use of copper carbonate and copper nanoparticles in the diet of rats on the level of \u03b2-amyloid and acetylcholinesterase in selected organs. J Trace Elem Med Biol 2021,67,126777","journal-title":"J Trace Elem Med Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.2147\/IJN.S212387","volume":"14","author":"Tahaei G.S.S.","year":"2019","unstructured":"Tahaei G.S.S.; Yahya R.D.; Ahmed M.T.; Aziz F.M.; Shahpasand K.; Akhtari K.; Salihi A.; Abou-Zied O.K.; Falahati M.; \u03b1-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency. Int J Nanomedicine 2019,14,4637-4648","journal-title":"Int J Nanomedicine"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbrc.2008.06.035","volume":"373","author":"Wu W.","year":"2008","unstructured":"Wu W.; Sun X.; Yu Y.; Hu J.; Zhao L.; Liu Q.; Zhao Y.; Li Y.; TiO2 nanoparticles promote \u03b2-amyloid fibrillation in vitro. Biochem Biophys Res Commun 2008,373(2),315-318","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.3390\/ma15217664","volume":"15","author":"Slekiene N.","year":"2022","unstructured":"Slekiene N.; Snitka V.; Bruzaite I.; Ramanavicius A.; Influence of tio2 and zno nanoparticles on \u03b1-synuclein and \u03b2-amyloid aggregation and formation of protein fibrils. Materials (Basel) 2022,15(21),7664","journal-title":"Materials (Basel)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.15171\/ijb.1519","volume":"15","author":"Mohammadi S.","year":"2017","unstructured":"Mohammadi S.; Nikkhah M.; TiO nanoparticles as potential promoting agents of fibrillation of \u03b1-synuclein, a parkinson\u2019s disease-related protein. Iran J Biotechnol 2017,15(2),87-94","journal-title":"Iran J Biotechnol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3109\/21691401.2014.980507","volume":"44","author":"Wu J.","year":"2016","unstructured":"Wu J.; Xie H.; Effects of titanium dioxide nanoparticles on \u03b1-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons. Artif Cells Nanomed Biotechnol 2016,44(2),690-694","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1126\/science.8073293","volume":"265","author":"Bush A.","year":"1994","unstructured":"Bush A.; Pettingell W.; Multhaup G.; d Paradis M.; Vonsattel J.; Gusella J.; Beyreuther K.; Masters C.; Tanzi R.; Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 1994,265(5177),1464-1467","journal-title":"Science"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbagen.2018.10.004","volume":"1863","author":"Asthana S.","year":"2019","unstructured":"Asthana S.; Hazarika Z.; Nayak P.S.; Roy J.; Jha A.N.; Mallick B.; Jha S.; Insulin adsorption onto zinc oxide nanoparticle mediates conformational rearrangement into amyloid-prone structure with enhanced cytotoxic propensity. Biochim Biophys Acta, Gen Subj 2019,1863(1),153-166","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biochi.2021.10.011","volume":"193","author":"Yadav K.K.","year":"2022","unstructured":"Yadav K.K.; Ojha M.; Pariary R.; Arakha M.; Bhunia A.; Jha S.; Zinc oxide nanoparticle interface moderation with tyrosine and tryptophan reverses the pro-amyloidogenic property of the particle. Biochimie 2022,193,64-77","journal-title":"Biochimie"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00775-008-0461-9","volume":"14","author":"Talmard C.","year":"2009","unstructured":"Talmard C.; Leuma Yona R.; Faller P.; Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially \u03b1-helical conformer to aggregates of amyloid \u03b2 protein(1\u201328). J Biol Inorg Chem 2009,14(3),449-455","journal-title":"J Biol Inorg Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1021\/ja1007867","volume":"132","author":"Brender J.R.","year":"2010","unstructured":"Brender J.R.; Hartman K.; Nanga R.P.R.; Popovych N.; de la Salud Bea R.; Vivekanandan S.; Marsh E.N.G.; Ramamoorthy A.; Role of zinc in human islet amyloid polypeptide aggregation. J Am Chem Soc 2010,132(26),8973-8983","journal-title":"J Am Chem Soc"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"85485","DOI":"10.1117\/12.946606","volume":"8548","author":"Sukhanova A.","year":"2012","unstructured":"Sukhanova A.; Poly S.; Shemetov A.; Nabiev I.R.; Quantum dots induce charge-specific amyloid-like fibrillation of insulin at physiological conditions. SPIE Proceedings 2012,8548,85485","journal-title":"SPIE Proceedings"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866530666230705153229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/218450\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866530666230705153229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:47:50Z","timestamp":1696596470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/218450\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,9,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866530666230705153229","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-04-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}